TEX55
geneOn this page
Also known as FLJ32859TSCPA
Summary
TEX55 (testis expressed 55, HGNC:26553) is a protein-coding gene on chromosome 3q13.32, encoding Testis-specific expressed protein 55 (Q96M34).
Located in sperm flagellum.
Source: NCBI Gene 152405 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 9 total
- MANE Select transcript:
NM_152539
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26553 |
| Approved symbol | TEX55 |
| Name | testis expressed 55 |
| Location | 3q13.32 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ32859, TSCPA |
| Ensembl gene | ENSG00000163424 |
| Ensembl biotype | protein_coding |
| Entrez | 152405 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 4 protein_coding, 1 nonsense_mediated_decay
ENST00000295622, ENST00000460150, ENST00000473121, ENST00000492792, ENST00000494105
RefSeq mRNA: 1 — MANE Select: NM_152539
NM_152539
CCDS: CCDS2984
Canonical transcript exons
ENST00000295622 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001074350 | 119151224 | 119151456 |
| ENSE00001074351 | 119146165 | 119147587 |
| ENSE00003631311 | 119148180 | 119148323 |
Expression profiles
Bgee: expression breadth broad, 26 present calls, max score 95.22.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1069 / max 81.1953, expressed in 5 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 38072 | 0.0753 | 5 |
| 38071 | 0.0316 | 3 |
Top tissues by expression
91 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 95.22 | gold quality |
| right testis | UBERON:0004534 | 95.18 | gold quality |
| testis | UBERON:0000473 | 94.88 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.55 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 49.90 | gold quality |
| bone marrow cell | CL:0002092 | 41.22 | gold quality |
| ventricular zone | UBERON:0003053 | 41.12 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 36.85 | gold quality |
| calcaneal tendon | UBERON:0003701 | 36.74 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 36.45 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 36.15 | silver quality |
| granulocyte | CL:0000094 | 36.01 | gold quality |
| endometrium | UBERON:0001295 | 35.94 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 35.76 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| kidney | UBERON:0002113 | 34.33 | gold quality |
| bone marrow | UBERON:0002371 | 34.33 | gold quality |
| muscle tissue | UBERON:0002385 | 33.61 | gold quality |
| corpus callosum | UBERON:0002336 | 33.08 | gold quality |
| placenta | UBERON:0001987 | 32.51 | gold quality |
| right uterine tube | UBERON:0001302 | 31.70 | gold quality |
| leukocyte | CL:0000738 | 31.02 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 30.85 | gold quality |
| monocyte | CL:0000576 | 30.77 | gold quality |
| tonsil | UBERON:0002372 | 30.73 | gold quality |
| blood | UBERON:0000178 | 30.06 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.58 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.28 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
22 targeting TEX55, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-95-5P | 99.89 | 72.17 | 3973 |
| HSA-MIR-4307 | 99.82 | 70.45 | 3374 |
| HSA-MIR-4677-5P | 99.70 | 70.09 | 1940 |
| HSA-MIR-1284 | 99.67 | 73.56 | 1353 |
| HSA-MIR-7156-5P | 99.64 | 68.81 | 1369 |
| HSA-MIR-567 | 99.63 | 68.57 | 1219 |
| HSA-MIR-3123 | 99.47 | 67.15 | 2693 |
| HSA-MIR-1276 | 99.36 | 68.18 | 1642 |
| HSA-MIR-4999-5P | 99.35 | 69.15 | 926 |
| HSA-MIR-4311 | 99.31 | 70.47 | 3041 |
| HSA-MIR-6739-3P | 99.22 | 68.84 | 1843 |
| HSA-MIR-583 | 98.71 | 67.44 | 1791 |
| HSA-MIR-1537-5P | 98.70 | 68.33 | 999 |
| HSA-MIR-4718 | 98.55 | 68.61 | 814 |
| HSA-MIR-4790-3P | 96.63 | 67.08 | 806 |
Literature-anchored findings (GeneRIF, showing 1)
- TSCPA was expressed specifically in mouse and human testis and might play an important role in spermatogenesis. (PMID:19821082)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tex55 | ENSMUSG00000022798 |
| rattus_norvegicus | Tex55 | ENSRNOG00000042555 |
Paralogs (1): EFCAB10 (ENSG00000185055)
Protein
Protein identifiers
Testis-specific expressed protein 55 — Q96M34 (reviewed: Q96M34)
Alternative names: Testis-specific conserved, cAMP-dependent type II PK-anchoring protein
All UniProt accessions (5): Q96M34, H7C4V1, H7C564, H7C5E0, S4R404
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Nucleus. Cell projection. Cilium. Flagellum.
Tissue specificity. Testis-specific.
RefSeq proteins (1): NP_689752* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR040760 | Tex55 | Family |
| IPR048377 | TEX55_DD | Domain |
Pfam: PF17819
UniProt features (18 total): compositionally biased region 9, sequence variant 6, region of interest 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96M34-F1 | 48.94 | 0.08 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 21 (showing top):
GSE45365_NK_CELL_VS_CD8A_DC_DN, GOCC_MOTILE_CILIUM, GOCC_CILIUM, GOCC_9PLUS2_MOTILE_CILIUM, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, MIR4307, MIR4311, MIR4677_5P, MIR3123, MIR4999_5P, MIR4790_3P, chr3q13, PAX6_TARGET_GENES, GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_DN, GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (5): nucleus (GO:0005634), sperm flagellum (GO:0036126), cilium (GO:0005929), motile cilium (GO:0031514), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| 9+2 motile cilium | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| cilium | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
216 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TEX55 | PRSS54 | Q6PEW0 | 643 |
| TEX55 | EFCAB10 | A6NFE3 | 626 |
| TEX55 | GOLGA6L6 | A8MZA4 | 602 |
| TEX55 | SPMIP9 | Q96LM6 | 585 |
| TEX55 | CATIP | Q7Z7H3 | 582 |
| TEX55 | ROPN1B | Q9BZX4 | 570 |
| TEX55 | PRSS55 | Q6UWB4 | 549 |
| TEX55 | RIIAD1 | A6NNX1 | 529 |
| TEX55 | TPGS1 | Q6ZTW0 | 527 |
| TEX55 | C8orf34 | Q49A92 | 506 |
| TEX55 | GOLGA6L2 | Q8N9W4 | 506 |
| TEX55 | FBXL13 | Q8NEE6 | 454 |
| TEX55 | AK8 | Q96MA6 | 446 |
| TEX55 | ADAM32 | Q8TC27 | 442 |
| TEX55 | ADAM21 | Q9UKJ8 | 433 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| HTT | TEX55 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (2): C3orf30 (Cross-Linking-MS (XL-MS)), C3orf30 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A0A0P0XCU3, A0A1P8BH59, A1YFC1, A1YGK6, A2T7F2, A6NJ88, B7SY83, F1QU13, F4HXQ7, F4ICX9, F4INW9, F4KCE9, O04251, O81472, O96001, P0CV01, P0CV36, P0CV42, P0CV43, P0CV45, P0CV46, P0CV55, P0CV57, P0CV58, P10322, P16531, P48786, Q0DVU4, Q10P83, Q2EI21, Q3URU2, Q5JY77, Q5QNA6, Q5R7U0, Q5SRN2, Q5U4C1, Q5XPK0, Q6K5K2, Q7T2B3, Q8N3K9
Diamond homologs: A6X8Z9, Q96M34
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
9 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 8 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
340 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:119147588:G:GG | donor_gain | 0.9900 |
| 3:119147583:AATCT:A | donor_gain | 0.9800 |
| 3:119147584:ATCT:A | donor_gain | 0.9700 |
| 3:119159956:G:GG | donor_gain | 0.9700 |
| 3:119147585:TCT:T | donor_gain | 0.9600 |
| 3:119159955:A:AG | donor_gain | 0.9600 |
| 3:119147477:A:AG | donor_gain | 0.9400 |
| 3:119147478:G:GG | donor_gain | 0.9400 |
| 3:119147586:CT:C | donor_gain | 0.9400 |
| 3:119151289:AT:A | donor_gain | 0.9400 |
| 3:119147593:T:G | donor_gain | 0.9300 |
| 3:119147585:TCTGT:T | donor_loss | 0.8900 |
| 3:119147587:TGTAA:T | donor_loss | 0.8900 |
| 3:119147588:G:GA | donor_loss | 0.8900 |
| 3:119147589:TA:T | donor_loss | 0.8900 |
| 3:119147590:AAG:A | donor_loss | 0.8900 |
| 3:119147591:AGTTA:A | donor_loss | 0.8900 |
| 3:119147592:G:T | donor_loss | 0.8900 |
| 3:119147586:CTGT:C | donor_loss | 0.8700 |
| 3:119147587:TGTA:T | donor_loss | 0.8700 |
| 3:119147589:T:TG | donor_loss | 0.8700 |
| 3:119147590:AAGT:A | donor_loss | 0.8700 |
| 3:119147482:C:G | donor_gain | 0.8300 |
| 3:119147575:A:AG | donor_gain | 0.8300 |
| 3:119147576:G:GG | donor_gain | 0.8300 |
| 3:119148254:A:AG | acceptor_gain | 0.7900 |
| 3:119148255:G:GG | acceptor_gain | 0.7900 |
| 3:119150186:A:AG | acceptor_gain | 0.7400 |
| 3:119150187:A:G | acceptor_gain | 0.7000 |
| 3:119146312:G:GT | donor_gain | 0.6900 |
AlphaMissense
3553 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:119148318:T:C | F513L | 0.995 |
| 3:119148320:C:A | F513L | 0.995 |
| 3:119148320:C:G | F513L | 0.995 |
| 3:119151272:T:C | F531L | 0.995 |
| 3:119151274:T:A | F531L | 0.995 |
| 3:119151274:T:G | F531L | 0.995 |
| 3:119148283:T:C | L501P | 0.991 |
| 3:119148319:T:C | F513S | 0.991 |
| 3:119151240:T:C | L520S | 0.991 |
| 3:119151267:T:C | L529P | 0.990 |
| 3:119148300:C:G | H507D | 0.986 |
| 3:119148319:T:G | F513C | 0.986 |
| 3:119148301:A:C | H507P | 0.985 |
| 3:119148307:T:C | I509T | 0.985 |
| 3:119151276:T:G | M532R | 0.985 |
| 3:119151279:T:C | L533P | 0.985 |
| 3:119148310:T:C | L510P | 0.984 |
| 3:119151228:T:G | I516S | 0.983 |
| 3:119151243:T:A | V521D | 0.982 |
| 3:119151273:T:C | F531S | 0.982 |
| 3:119148307:T:G | I509S | 0.981 |
| 3:119151228:T:C | I516T | 0.981 |
| 3:119151276:T:C | M532T | 0.981 |
| 3:119151276:T:A | M532K | 0.980 |
| 3:119148288:T:G | Y503D | 0.979 |
| 3:119148289:A:C | Y503S | 0.979 |
| 3:119148265:A:G | D495G | 0.977 |
| 3:119148270:T:G | Y497D | 0.976 |
| 3:119148307:T:A | I509N | 0.976 |
| 3:119151264:C:A | P528H | 0.976 |
dbSNP variants (sampled 300 via entrez): RS1000892004 (3:119151167 C>A,G), RS1001376912 (3:119145615 T>C), RS1002524184 (3:119144688 TA>T,TAA), RS1002660393 (3:119151075 C>T), RS1003312681 (3:119147908 C>T), RS1003343776 (3:119147598 T>C), RS1003694840 (3:119148873 A>G), RS1004706235 (3:119145569 G>C), RS1004792538 (3:119145348 C>T), RS10049288 (3:119146065 G>A,T), RS1005081635 (3:119145743 G>A), RS1005460771 (3:119147956 A>G), RS1005760380 (3:119148259 A>G), RS1006350518 (3:119146901 C>T), RS1006790053 (3:119149129 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007643_2 | Gemcitabine-induced early high-grade neutropenia in pancreatic cancer | 5.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Permethrin | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): neutropenia